E. Dogan Et Al. , "Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma," MEDICAL ONCOLOGY , vol.27, no.4, pp.1436-1437, 2010
Dogan, E. Et Al. 2010. Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma. MEDICAL ONCOLOGY , vol.27, no.4 , 1436-1437.
Dogan, E., AKSOY, S., ARSLAN, Ç., ŞENER DEDE, D., & Altundag, K., (2010). Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma. MEDICAL ONCOLOGY , vol.27, no.4, 1436-1437.
Dogan, Erkan Et Al. "Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma," MEDICAL ONCOLOGY , vol.27, no.4, 1436-1437, 2010
Dogan, Erkan Et Al. "Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma." MEDICAL ONCOLOGY , vol.27, no.4, pp.1436-1437, 2010
Dogan, E. Et Al. (2010) . "Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma." MEDICAL ONCOLOGY , vol.27, no.4, pp.1436-1437.
@article{article, author={Erkan Dogan Et Al. }, title={Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma}, journal={MEDICAL ONCOLOGY}, year=2010, pages={1436-1437} }